Copyright: ©Author(s) 2026.
World J Gastroenterol. Jul 28, 2026; 32(28): 121267
Published online Jul 28, 2026. doi: 10.3748/wjg.121267
Published online Jul 28, 2026. doi: 10.3748/wjg.121267
Table 3 Diagnostic performance of high-sensitivity quantitative fecal immunochemical test across different disease groups
| Disease group | Sensitivity (95%CI) | Specificity (95%CI) | PPV (95%CI) | NPV (95%CI) | LR+ | LR- | AUC (95%CI) |
| Adenoma | 37.5% (22.9%-54.3%) | 92.5% (79.7%-98.1%) | 83.3% (60.5%-95.4%) | 59.7% (46.6%-71.6%) | 5 (1.9-13.2) | 0.68 (0.5-0.9) | 0.653 (0.532-0.774) |
| CRC | 80% (64.4%-90.5%) | 92.5% (79.7%-98.1%) | 91.4% (77.2%-97.8%) | 82.2% (67.9%-91.5%) | 10.67 (3.55-32) | 0.22 (0.12-0.4) | 0.872 (0.786-0.958) |
| Presence of intestinal lesions | 58.8% (47.1%-69.7%) | 92.5% (79.7%-98.1%) | 94% (83%-98.6%) | 52.9% (40.6%-64.9%) | 7.84 (2.6-23.6) | 0.45 (0.34-0.59) | 0.762 (0.677-0.848) |
- Citation: Jing W, Qin L, Zhang XH, Pan F, Ren RR, Li Y, Zhang Y, Peng LH, Wang ZK, Zhang XL. Diagnostic efficacy of fecal calprotectin combined with a high-sensitivity quantitative fecal immunochemical test for colorectal tumors. World J Gastroenterol 2026; 32(28): 121267
- URL: https://www.wjgnet.com/1007-9327/full/v32/i28/121267.htm
- DOI: https://dx.doi.org/10.3748/wjg.121267